Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes

Diabetologia

Volumn 51, Issue 11, 2008, Pages 2031-2040

  Basu, R ^a   Basu, A ^a   Chandramouli, V ^b   Norby, B ^a   Dicke, B ^a   Shah, P ^c   Cohen, O ^d   Landau, B R ^b   Rizza, R A ^a  

^a Mayo Clinic   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

Gluconeogenesis; Glycogenolysis; Insulin resistance; Metformin; Non esterified fatty acids; Thiazolidinediones; Type 2 diabetes

Indexed keywords

C PEPTIDE; FATTY ACID; GLUCAGON; GLUCOSE; GLYCEROL; HEPARIN; INSULIN; INTRALIPID; METFORMIN; PIOGLITAZONE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; FEMALE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCEROL BLOOD LEVEL; GLYCOGENOLYSIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCAGON; GLUCONEOGENESIS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLYCEROL; HEPARIN; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METFORMIN; MIDDLE AGED; THIAZOLIDINEDIONES;

EID: 53549113036     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-008-1138-1     Document Type: Article

References (51)

1. D Kerpichnikov SI McFarlane JR Sowers 2002 Metformin: an update Ann Intern Med 137 25 33
2. DM Nathan 2002 Initial management of glycemia in type 2 diabetes mellitus N Engl J Med 347 1342 1349
3. SE Inzucchi 2002 Oral antihyperglycemic therapy for type 2 diabetes: scientific review JAMA 287 360 372
4. J-M Ye N Dzamko ME Cleasby 2004 Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin Diabetologia 47 1306 1313
5. ME Cleasby N Dzamko BD Hegarty GJ Cooney EW Kraegen J-M Ye 2004 Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms Diabetes 53 3258
6. CA Collier CR Bruce AC Smith G Lopaschuk DJ Dyck 2006 Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle Am J Physiol Endocrinol Metab 291 E182 E189
7. MK Todd MJ Watt J Le AL Hevener LP Turcotte 2007 Thiazolidinediones enhance skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance Am J Physiol Endocrinol Metab 292 E485 E493
8. AB Mayerson RS Hundal S Dufour 2002 The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes Diabetes 51 797 802
9. Y Miyazaki L Glass C Triplitt 2001 Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in type II diabetic patients Diabetologia 44 2210 2219
10. M Tiikkainen M Tamminen A-M Häkkinen 2002 Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes Obes Res 10 859 867
11. JM Miles D Wooldridge WJ Grellner 2003 Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy Diabetes 52 675 681
12. J Tonelli W Li P Kishore 2004 Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes Diabetes 53 1621 1629
13. DG Maggs TA Buchanan CF Burant 1998 Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial Ann Intern Med 128 176 185
14. KA Virtanen K Hällstenh R Parkkola 2003 Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects Diabetes 52 283 290
15. G Boden P Cheung M Mozzoli SK Fried 2003 Effects of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes Metabolism 52 753 759
16. AL Hevener D Reichart A Janez J Olefsky 2001 Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male Wistar rats Diabetes 50 2316 2322
17. J-M Ye G Frangioudakis MA Iglesias 2002 Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver Endocrinology 143 4527 4535
18. S Dhindsa D Tripathy N Sanalkumar 2005 Free fatty acid-induced insulin resistance in the obese is not prevented by rosiglitazone treatment J Clin Endocrinol Metab 90 5058 5063
19. MJ Serlie G Allick JE Groener 2007 Chronic treatment with pioglitazone does not protect obese patients with diabetes mellitus type II from free fatty acid-induced insulin resistance J Clin Endocrinol Metab 92 166 171
20. R Basu P Shah A Basu 2008 Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes Diabetes 57 24 31
21. 2O administration Anal Biochem 297 195 197
22. J Miles R Glasscock J Aikens J Gerich M Haymond 1983 A microfluorometric method for the determination of free fatty acids in plasma J Lipid Res 24 96 99
23. R Steele J Wall R DeBodo N Altszuler 1956 Measurement of size and turnover rate of body glucose pool by the isotope dilution method Am J Physiol 187 15 24
24. R Basu V Chandramouli B Dicke B Landau R Rizza 2005 Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis Diabetes 54 1942 1948
25. M Tiikainen A-M Hakkinen E Korsheninnikova T Nyman S Makimattila H Yki-Jarvinen 2004 Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes Diabetes 53 2169 2176
26. A Gastaldelli Y Miyazaki A Mahankali 2006 The effect of pioglitazone on the liver: role of adiponectin Diabetes Care 29 2275 2281
27. A Gastaldelli Y Miyazaki M Pettiti 2006 The effect of rosiglitazone on the liver: decreased gluconeogenesis in patients with type 2 diabetes J Clin Endocrinol Metab 91 806 812
28. GF Davies RL Khandelwal L Wu BHJ Juurlink WJ Roesler 2001 Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-g (PPARg)-independent, antioxidant-related mechanism Biochem Pharmacol 62 1071 1079
29. J-P Fulgencio C Kohn J Girard J-P Pégorier 1996 Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats Diabetes 45 1556 1562
30. I Grosskopf Y Ringel G Charach 1997 Metformin enhances clearance of chylomicrons and chylomicron remnants in nondiabetic mildly overweight glucose-intolerant subjects Diabetes Care 20 1598 1602
31. S Song S Andrikopoulos C Filippis AW Thorburn D Khan J Proietti 2001 Mechanism of fat-induced hepatic gluconeogenesis: effect of metformin Am J Physiol Endocrinol Metab 281 E275 E282
32. G Zhou R Myers Y Li 2001 Role of AMP-activated protein kinase in mechanism of metformin action J Clin Invest 108 1167 1174
33. S Del Prato S Marchetto A Pipitone M Zanon S de Kreutzenberg A Tiengo 1995 Metformin and free fatty acid metabolism Diabetes Metab Rev 11 S33 S41
34. LJ Dominguez AJ Davidoff PR Srinivas PR Standley MF Walsh JR Sowers 1996 Effects of metformin on tyrosine kinase activity, glucose transport, and intracellular calcium in rat vascular smooth muscle Endocrinology 137 113 121
35. JE Gunton PJD Delhanty S-I Takahashi RC Baxter 2003 Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2 J Clin Endocrinol Metab 88 1323 1332
36. RS Hundal M Krssak S Dufour 2000 Mechanism by which metformin reduces glucose production in type 2 diabetes Diabetes 49 2063 2069
37. M Stumvoll N Nurjhan G Perriello G Dailey JE Gerich 1995 Metabolic effects of metformin in non-insulin-dependent diabetes mellitus N Engl J Med 333 550 554
38. A Natali E Ferrannini 2006 Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review Diabetologia 49 434 441
39. DC Simonson E Ferrannini S Bevilacqua 1984 Mechanism of improvement in glucose metabolism after chronic glyburide therapy Diabetes 33 838 845
40. R Firth P Bell M Marsh RA Rizza 1987 Effects of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with non-insulin-dependent diabetes mellitus Diabetes 36 1130 1138
41. GD Tan BA Fielding JM Currie 2005 The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes Diabetologia 48 83 95
42. JP van Wijk EJ de Koning M Castro Cabezas TJ Rabelink 2005 Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes Diabetes Care 28 844 849
43. BR Landau J Wahren V Chandramouli WC Schumann K Ekberg 1995 Use of 2H2O for estimating rates of gluconeogenesis: application to the fasted state J Clin Invest 95 172 178
44. 2O to measure gluconeogenesis in humans Diabetes 57 50 55
45. H Yki-Jarvinen 1992 Glucose toxicity Endocr Rev 13 415 431
46. M Roden H Stingl V Chandramouli 2000 Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans Diabetes 49 701 707
47. JN Clore PS Glickman JE Nestler WG Blackard 1991 In vivo evidence for hepatic autoregulation during NEFA-stimulated gluconeogenesis in normal humans Am J Physiol 261 E425 E429
48. TKT Lam A Carpentier GF Lewis G Van De Werve IG Fantus A Giacca 2003 Mechanisms of the free fatty acid-induced increase in hepatic glucose production Am J Physiol Endocrinol Metab 284 E863 E873
49. X Chen N Iqbal G Boden 1999 The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects J Clin Invest 103 365 372
50. G Boden P Cheung TP Stein K Kresge M Mozzoli 2002 NEFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis Am J Physiol Endocrinol Metab 283 E12 E19
51. SP Kim KJ Catalano IR Hsu JD Chiu JM Richey 2007 Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia Am J Physiol Endocrinol Metab 292 E1590 E1598